Zhengye Biotechnology Holding Limited Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Zhengye Biotechnology Holding Limited (ZYBT) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -CNY 8.75 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-07-03.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2025-07-03
CNY
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|
| 2024-12-31 | -8.75M CNY 20-F · filed 2025-07-03 |
| 2023-12-31 | 17.44M CNY 20-F · filed 2025-07-03 |
| 2022-12-31 | 3.46M CNY 20-F · filed 2025-07-03 |
USD
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|
| 2024-12-31 | -$1.20M 20-F · filed 2025-07-03 |